In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
about
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismDopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptorsGenetic variation in cortico-amygdala serotonin function and risk for stress-related diseaseChanges in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockersThe stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.5-HT2 ligands in the treatment of anxiety and depression.Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.Expression of α(1)-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT(2A) receptors.5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.Activation of 5-HT2A receptor disrupts rat maternal behavior.Effects of Hallucinogens on Neuronal Activity.Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei.Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-).
P2860
Q24595389-CFF561B0-ABCC-4D1A-B1AA-42BEA6A9DF1EQ28080944-D802AEDF-C42C-4267-8A10-23D5E9F0904BQ28084069-097C94C6-9158-4BE3-87A5-A4AD5E46B6F4Q28273285-E5F08C32-4EA4-4AB7-A4F3-640BBA9A1E88Q30487278-D143A1C3-7367-4C90-989C-3C1185B151EDQ33764320-038A3EDE-7A7E-4C5D-8EF9-32E0E465EC55Q36569606-0B2E05EC-644F-43DC-AA9B-C0279C978F72Q38037141-43F641FE-2F8B-470C-9B16-5318FAD97A29Q42036562-4A87E8BF-8583-48B6-B929-7F7BDE3EE015Q45100662-333CA135-8872-482A-A1F6-0E3662F935AEQ45902720-87A7DEF9-9074-455E-8CC0-C5702333B100Q46128379-FE3A061B-3CB5-4506-AA04-5B9381C66C06Q47317394-C077F83B-8D74-42D1-BB58-7A4B669FC770Q47791105-8B94565B-EB9C-4AA8-A8A9-AFF68608990AQ48224639-2A4CD7B1-0E1B-42CA-A576-E823379E6C25Q48245461-A6C5F016-E458-47AD-B28E-3C93FC3ADBA3Q48351743-4BAD34B5-8F5E-405A-BC6B-643C6A1A415C
P2860
In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
In vivo modulation of 5-hydrox ...... refrontal cortex by local 5-HT
@nl
In vivo modulation of 5-hydrox ...... effect of antipsychotic drugs.
@en
type
label
In vivo modulation of 5-hydrox ...... refrontal cortex by local 5-HT
@nl
In vivo modulation of 5-hydrox ...... effect of antipsychotic drugs.
@en
prefLabel
In vivo modulation of 5-hydrox ...... refrontal cortex by local 5-HT
@nl
In vivo modulation of 5-hydrox ...... effect of antipsychotic drugs.
@en
P2093
P2860
P50
P1476
In vivo modulation of 5-hydrox ...... effect of antipsychotic drugs
@en
P2093
Francesc Artigas
Jordi Serrats
Mercè Amargós-Bosch
P2860
P304
P356
10.1046/J.1460-9568.2003.02829.X
P407
P577
2003-09-01T00:00:00Z